These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9476067)

  • 21. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
    Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.
    Qiu J; Yu Y; Fu Y; Ye F; Xie X; Lu W
    J Obstet Gynaecol Res; 2012 Apr; 38(4):651-7. PubMed ID: 22413879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative thrombocytosis in surgically treated patients with non-small cell lung cancer.
    Skorek P; Stępień K; Fila M; Hauer J; Kużdżał J
    Pol Arch Intern Med; 2018 Sep; 128(9):512-517. PubMed ID: 30057382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of thrombocytosis on clinicopathological prognostic factors and survival in patients with vulvar cancer.
    Uysal A; Gültekin E; Taner CE; Mun S; Yidirim Y
    Ginekol Pol; 2013 Jun; 84(6):450-5. PubMed ID: 24032263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
    Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
    BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets are not hyperreactive in patients with ovarian cancer.
    Feng S; Kroll MH; Nick AM; Sood AK; Afshar-Kharghan V
    Platelets; 2016 Nov; 27(7):716-718. PubMed ID: 27185008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
    Heng S; Benjapibal M
    Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
    Ye Q; Cheng J; Ye M; Liu D; Zhang Y
    J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
    Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
    Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
    Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
    Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytosis as a prognostic factor in endometrial carcinoma.
    Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
    Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombocytosis as a prognostic factor in women with cervical cancer.
    Lopes A; Daras V; Cross PA; Robertson G; Beynon G; Monaghan JM
    Cancer; 1994 Jul; 74(1):90-2. PubMed ID: 8004588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of preoperative thrombocytosis in epithelial ovarian cancer.
    Crasta JA; Premlatha TS; Krishnan SM; Vallikad E; Rameshkumar K
    Indian J Pathol Microbiol; 2010; 53(1):54-6. PubMed ID: 20090223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between platelet count and CA-125 in ovarian cancer].
    Friebe Z; Watrowski R; Bembnista M; Rokowska A; Włosiińska J; Dembińska M
    Ginekol Pol; 2005 Mar; 76(3):187-94. PubMed ID: 16018136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.
    Matsuo K; Hasegawa K; Yoshino K; Murakami R; Hisamatsu T; Stone RL; Previs RA; Hansen JM; Ikeda Y; Miyara A; Hiramatsu K; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Roman LD; Gabra H; Fotopoulou C; Sood AK
    Eur J Cancer; 2015 Sep; 51(14):1978-88. PubMed ID: 26238017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.